Home > Journals > Panminerva Medica > Past Issues > Articles online first > Panminerva Medica 2022 Apr 06



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as


Original Article   

Panminerva Medica 2022 Apr 06

DOI: 10.23736/S0031-0808.22.04719-X


language: English

Effect of contrast-enhanced ultrasound (CEUS) on liver stiffness measurements obtained by transient and shear-wave elastography

Stefano KAYALI 1, Andrea PASTA 1, Rinaldo PELLICANO 2, Sharmila FAGOONEE 3, Elisabetta GIULIANA 1, Chiara FACCHINI 1, Simona PILI 4, Silvia BUCCILLI 1, Sara LABANCA 1, Paolo BORRO 5

1 Gastroenterology clinic, IRCCS Policlinico San Martino, Genoa, Italy; 2 Unit of Gastroenterology, Molinette-SGAS Hospital Turin, Italy; 3 National Research Council, Molecular Biotechnology Center (CNR), Turin,Italy; 4 SC Pharmacy ASL3, Villa Scassi Hospital, Genoa, Italy; 5 Hepatobiliopancreatic and Liver transplant Surgery Unit, IRCCS Policlinico San Martino, Genoa, Italy


BACKGROUND: Since liver fibrosis is one of the most accurate predictors of prognosis in hepatopatic patients, its accurate assessment and staging is a major public health issue. Transient elastography (TE, Fibroscan®) and shear wave elastography (SWE) represent the gold standard techniques among non-invasive methods to assess liver fibrosis. Contrast-enhanced ultrasound (CEUS) is increasingly used to diagnose the nature of liver lesions and is often performed together with TE and SWE. In this study we evaluated the effect of CEUS on liver stiffness measurements obtained by TE and SWE.
METHODS: A retrospective analysis of ultrasound (US) exams performed by an expert operator was carried out. TE and SWE were performed 30 seconds before and after the execution of CEUS. Statistical analysis was carried out using the statistical software R. Kolmogorov-Smirnov analysis was performed to test the normality of continuous variables. The pre- and post-CEUS liver stiffness values were compared using the Wilcoxon’s test.
RESULTS: Ninety-six patients were enrolled. While the measurements were comparable when performed with TE, those obtained by SWE decreased by 6% after administration of the contrast agent (P= 0.0005). Fibrosis stage deviated between pre- and post-CEUS in 16 (17%) patients with Fibroscan® and 22 (23%) patients with SWE. Among the latter, in 9 cases (10%) a deviation from absent-low (F0-F2) to high-fibrosis (F3, F4), or vice versa, occurred.
CONCLUSIONS: Our study, the first to assess the effects of CEUS on US elastography, shows that the contrast agent (Sonovue®) does not significantly affect liver stiffness measurements obtained by TE, whereas the accuracy decreases when performed by SWE.

KEY WORDS: Liver fibrosis; Liver disease ultrasound; Elastography; Shear wave elastography

top of page